| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.375 | 97.052 | 194.193 | 83.968 | 113.346 | 90.910 | 135.168 | 108.599 | 132.143 | 41.481 |
| Total Income - EUR | 24.375 | 97.053 | 194.197 | 83.976 | 113.691 | 106.846 | 136.800 | 109.106 | 132.532 | 42.112 |
| Total Expenses - EUR | 1.191 | 45.638 | 76.390 | 71.591 | 77.445 | 83.702 | 70.350 | 60.005 | 148.870 | 61.113 |
| Gross Profit/Loss - EUR | 23.184 | 51.415 | 117.807 | 12.384 | 36.246 | 23.145 | 66.450 | 49.101 | -16.337 | -19.000 |
| Net Profit/Loss - EUR | 22.453 | 49.396 | 114.887 | 11.545 | 35.111 | 22.260 | 64.664 | 45.994 | -17.462 | -19.421 |
| Employees | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Center For Health Outcomes & Evaluation Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 104 | 2.501 | 1.595 | 2.792 | 1.085 | 3.052 | 933 | 7.038 | 596 | 0 |
| Current Assets | 30.446 | 59.424 | 152.967 | 121.290 | 152.173 | 156.428 | 221.008 | 202.163 | 164.909 | 28.834 |
| Inventories | 0 | 448 | 0 | 0 | 0 | 0 | 1 | 5.007 | 0 | 175 |
| Receivables | 30.313 | 9.523 | 114.226 | 54.785 | 58.824 | 53.664 | 29.692 | 52.785 | 104.823 | 8.313 |
| Cash | 133 | 49.453 | 38.740 | 66.506 | 93.348 | 102.764 | 191.314 | 144.371 | 60.086 | 20.347 |
| Shareholders Funds | 22.498 | 50.569 | 116.041 | 106.229 | 35.161 | 56.755 | 120.160 | 166.527 | 148.560 | -4.985 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.052 | 11.356 | 38.521 | 18.163 | 118.096 | 102.725 | 101.781 | 42.674 | 16.945 | 33.819 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7220 - 7220" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Center For Health Outcomes & Evaluation Srl